Eva Papp

Characterization of human type I and type II IMP dehydrogenases.

Stephen F. Carr, Eva Papp, J. Wu et al. · Journal of Biological Chemistry · 1993 · 421 citations · Full text

Type Ii Enzyme, Aldo-keto Reductase, Genetics +16

Molecular Mechanism of the Syk Activation Switch

Emily K. Tsang, Anthony M. Giannetti, David E. Shaw et al. · Journal of Biological Chemistry · 2008 · 160 citations · Full text

Design and Synthesis of 4-Azaindoles as Inhibitors of p38 MAP Kinase

Alejandra Trejo, Humberto Arzeno, Michelle F. Browner et al. · Journal of Medicinal Chemistry · 2003 · 94 citations · Full text

Combinatorial Chemistry, Bioorganic Chemistry, P38 Map Kinase +17

Pamapimod, a Novel p38 Mitogen-Activated Protein Kinase Inhibitor: Preclinical Analysis of Efficacy and Selectivity

Ronald J. Hill, Karim Dabbagh, Deborah Phippard et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 78 citations

Discovery of 6-(2,4-Difluorophenoxy)-2-[3-hydroxy-1-(2-hydroxyethyl)propylamino]-8-methyl-8<i>H</i>-pyrido[2,3-<i>d</i>]pyrimidin-7-one (Pamapimod) and 6-(2,4-Difluorophenoxy)-8-methyl-2-(tetrahydro-2<i>H</i>-pyran-4-ylamino)pyrido[2,3-<i>d</i>]pyrimidin-7(8<i>H</i>)-one (R1487) as Orally Bioavailable and Highly Selective Inhibitors of p38α Mitogen-Activated Protein Kinase

David Goldstein, Michael Soth, Tobias Gabriel et al. · Journal of Medicinal Chemistry · 2011 · 74 citations · Full text

Pharmacotherapy, New Series, System Pharmacology +21